Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACUTE
NCT07258771Phase 4Recruiting
- Start
- Jan 2026
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of upadacitinib in ulcerative colitis (UC). Started Jan 2026; status: recruiting.
02
Drugs
upadacitinib
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07258771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07258771.